arrow
M

Marc Zapatka

german cancer research center
H指数:63
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency

Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency 不同小脑髓母细胞瘤染色质状态揭示KDM2B为一种选择性依赖

2026-09-240
OA
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

在转移性乳腺癌中实施精准肿瘤学:全面基因组分析的临床影响——CATCH研究经验

2025-10-310
OAAI
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard

Pipeline Olympics:针对DNA甲基化测序数据,基于实验金标准的可延续性计算工作流基准测试

2025-10-280
OAAI
P11.37.B NOVEL PATIENT-DERIVED BREAST CANCER BRAIN METASTASES MODELS CHARACTERIZED BY LARGE-SCALE DRUG SCREENING AND INTEGRATIVE MULTI-OMICS PROFILING

P11.37.B 基于患者来源的乳腺癌脑转移瘤新型模型,通过大规模药物筛选和整合多组学分析进行表征

2025-10-030
OA
DISSECTING THE CELLULAR ARCHITECTURE OF BREAST CANCER BRAIN METASTASES REVEALS PROGNOSTICALLY DISTINCT IMMUNE LANDSCAPES

剖析乳腺癌脑转移的细胞架构揭示出预后不同的免疫景观

2025-10-010
OAAI
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target

整合多组学揭示CLL中调节性及耗竭性T细胞景观,并鉴定出galectin-9作为免疫治疗靶点

2025-08-070
OA
Biopsy-derived organoids in personalised early breast cancer care: Challenges of tumour purity and normal cell overgrowth cap their practical utility
2025-02-010
OAAI
COGNITION/-GUIDE - Implementation of Precision Oncology in Early High-Risk Breast Cancer
2024-05-020
PRE
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

认知: 新辅助化疗后高危早期乳腺癌患者的前瞻性精确肿瘤学试验

2022-12-016
OAAI
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
2022-10-2020
OAAI
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly- informed therapies despite heterogeneity
2022-08-0227
OAAI
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis
2022-04-286
OA
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity
IMMUNITY
IF26.3
2021-12-0172
OAAI